Power Law company profile

Apogee Therapeutics

Biotech & Life Sciences · Waltham, United States · Founded 2022 · IPO 2023 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$6.56B

Market cap · Apr/2026

Investors

9 investors on Apogee Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Venrock Healthcare Capital Partners

Fairmount Funds Management

Series B+ 7 investors entered at this stage

RA Capital Management

Deep Track Capital

Perceptive Xontogeny Venture Fund

RTW Investments

OrbiMed

Fidelity Investments

Wellington Management

Global footprint

Where Apogee Therapeutics has talent and traffic

Web traffic by country

70K monthly visits
across markets

🇪🇸 Spain57.6%

🇺🇸 United States34.4%

🇬🇧 United Kingdom1.9%

🇨🇦 Canada1.4%

🇩🇪 Germany1%

Top 5 markets shown

Patent intelligence

$184k patent portfolio · 5 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$184k

<0.01% of market cap · 1779.6× smaller than top peer Genmab ($328M)

5 active patent families

Where Apogee Therapeutics innovates Antiendomysial antibodiesMolecular biologyBiological activityAnti antibodyDrug biological activity

Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Apogee Therapeutics on the five Patsnap quality dimensions

Apogee Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Apogee Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Apogee Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Apogee Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo